Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (4946)	3/10/1999 7:21:00 PM
From: JanyBlueEyes	Read Replies (1) \| Respond to of 5736

Cacaito You go ahead and call Spectrx and ask them if their FDA approved device can be used at any time during and/or after phototherapy treatment. (Phototherapy treatment is when you put a protective covering on the infant's eyes and put them under what looks like "florescent lights" that shine on to the baby's skin and reduces the amount of bilirubin in the blood.) The changes in the infant's skin due to phototherapy (tanning, redness can occur) renders the Spectrx device unusable. It can not read the correct level of bilirubin once phototherapy treatment is applied. Another difference in the two devices is that Chromatics' device has the ability to store the different readings and the data can be downloaded into the patient records on the hospital's computers. Spectrx's is a one shot deal.